{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:11:20Z","timestamp":1759947080705,"version":"build-2065373602"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UNITAID","award":["2017-16-PSI-STAR"],"award-info":[{"award-number":["2017-16-PSI-STAR"]}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>World Health Organization recommends antigen rapid diagnostic tests (RDT) as point of care tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in suspected outbreaks when polymerase-chain-reaction testing is not accessible; to trace the extent of outbreaks; and in areas with widespread community transmission. Annual economic costs were estimated for professional SARS-CoV-2 testing as part of several COVID-19 testing use cases in Malawi, Nigeria and Zimbabwe. Symptom screening and antigen-based RDT was implemented as part of a multi-country, Unitaid\/STAR 3ACP (Africa, Asia, America COVID-19 Prevention) funded project (April 2022-June 2023). Testing services were provided through trained health providers in outpatient departments of primary care facilities (Malawi and Nigeria) and two primary non governmental organisation (NGO) use cases separately targeting key population (KP) and the general population in Zimbabwe. Combined financial expenditure analysis and on-site micro-costing took the provider\/health system perspective in 2025 US$. Per test average costs were $9.73 (range across sites: $5.49-$29.90) in Malawi, $13.99 ($11.64-US$18) in Nigeria and $10.11 ($4.19-$209.09) and $19.98 ($10.76-$56.40) in Zimbabwe for general population and key population clinics respectively. Average costs per positive case identified were $521 ($61-$800) in Malawi; $1,118 ($202.66-$4,804.45) in Nigeria; and $1,125 ($336-$ 1,762) and $187 ($161-$ 1,272) in Zimbabwe. Major cost contributors were test kits in Malawi, test kits and building (consultation room space costs) and storage in Nigeria and personnel and training in Zimbabwe. Excluding above site level costs, the average cost per SARS-CoV-2 test was $9.73 in Malawi, $13.99 in Nigeria and $10.70 and $9.79 in Zimbabwe. Integrating COVID-19 testing into existing sites can reach people at high risk of severe illness at a reasonable cost. For resource-limited settings where programmes are threatened by low fiscal space, costs might be reduced when scaling up, through greater spreading of startup and capital costs.<\/jats:p>","DOI":"10.1371\/journal.pgph.0005251","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:31:03Z","timestamp":1759944663000},"page":"e0005251","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Provider costs of professional COVID-19 rapid antigen testing in low-income settings"],"prefix":"10.1371","volume":"5","author":[{"given":"Collin","family":"Mangenah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucky G.","family":"Ngwira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0879-3861","authenticated-orcid":true,"given":"Obinna","family":"Ekwunife","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Sande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1085-6128","authenticated-orcid":true,"given":"Progress","family":"Chiwawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linea","family":"Mashoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiderata","family":"Nkhoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norah","family":"Mwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-2218","authenticated-orcid":true,"given":"Elvis","family":"Isere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itai","family":"Kabonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constancia","family":"Watadzaushe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudo","family":"Chinoruma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1707-0577","authenticated-orcid":true,"given":"Yasmin","family":"Dunkley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine","family":"Choko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Bimba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Maponga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6522-7167","authenticated-orcid":true,"given":"Noah","family":"Taruberekera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euphemia","family":"Sibanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances M.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-3732","authenticated-orcid":true,"given":"Karin","family":"Hatzold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth L.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"1","key":"pgph.0005251.ref001","first-page":"157","article-title":"WHO Declares COVID-19 a Pandemic","volume":"91","author":"D Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"pgph.0005251.ref002","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.p1041","article-title":"Covid-19: WHO declares end of global health emergency","volume":"381","author":"J Wise","year":"2023","journal-title":"BMJ"},{"key":"pgph.0005251.ref003","unstructured":"Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). 2020."},{"key":"pgph.0005251.ref004","doi-asserted-by":"crossref","unstructured":"Organisation WH. COVID-19 epidemiological update - 29 September 2023. 2023. https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update---29-september-2023","DOI":"10.4324\/9781003424451-5"},{"key":"pgph.0005251.ref005","volume-title":"Therapeutics and COVID-19: Living Guideline","author":"World Health Organization WH","year":"2021"},{"issue":"14","key":"pgph.0005251.ref006","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJMoa2119658","article-title":"Population Immunity and Covid-19 Severity with Omicron Variant in South Africa","volume":"386","author":"SA Madhi","year":"2022","journal-title":"N Engl J Med"},{"key":"pgph.0005251.ref007","unstructured":"Nations U. WHO chief declares end to COVID-19 as a global health emergency. 2023. https:\/\/www.un.org\/en\/coronavirus"},{"issue":"15","key":"pgph.0005251.ref008","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19","volume":"386","author":"J Hammond","year":"2022","journal-title":"N Engl J Med"},{"issue":"25","key":"pgph.0005251.ref009","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.jacc.2008.09.018","article-title":"Interpreting the results of cost-effectiveness studies","volume":"52","author":"DJ Cohen","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"6525","key":"pgph.0005251.ref010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.abe9187","article-title":"COVID-19 testing: One size does not fit all","volume":"371","author":"MJ Mina","year":"2021","journal-title":"Science"},{"key":"pgph.0005251.ref011","volume-title":"Antigen-detection in the diagnosis of SARS-CoV-2 infection: interim guidance","author":"Organization WH","year":"2021"},{"issue":"3","key":"pgph.0005251.ref012","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMcp2117115","article-title":"Rapid Diagnostic Testing for SARS-CoV-2","volume":"386","author":"PK Drain","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"pgph.0005251.ref013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-010690","article-title":"Is there a role for RDTs as we live with COVID-19? An assessment of different strategies","volume":"8","author":"G Bonnet","year":"2023","journal-title":"BMJ Glob Health"},{"issue":"7","key":"pgph.0005251.ref014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004429","article-title":"Cost-effectiveness of COVID rapid diagnostic tests for patients with severe\/critical illness in low- and middle-income countries: A modeling study","volume":"21","author":"G Bonnet","year":"2024","journal-title":"PLoS Med"},{"key":"pgph.0005251.ref015","volume-title":"Market and technology landscape: HIV rapid diagnostic tests for self-testing","author":"Unitaid WHO","year":"2018"},{"key":"pgph.0005251.ref016","unstructured":"Malawi U. Population matters. 2018. https:\/\/malawi.unfpa.org\/en\/topics\/population-matters-4"},{"key":"pgph.0005251.ref017","unstructured":"Nigeria U. Nigeria - Overview. 2023. https:\/\/www.unfpa.org\/data\/world-population\/NG"},{"key":"pgph.0005251.ref018","unstructured":"ZIMSTAT. Total population. 2023. https:\/\/www.zimstat.co.zw"},{"key":"pgph.0005251.ref019","unstructured":"O WH. COVID-19 overview. 2023. https:\/\/covid19.who.int\/region\/afro\/country\/zw"},{"issue":"7","key":"pgph.0005251.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289291","article-title":"COVID-19 self-testing using antigen rapid diagnostic tests: Feasibility evaluation among health-care workers and general population in Malawi","volume":"18","author":"M Mukoka","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"pgph.0005251.ref021","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s12913-020-05379-z","article-title":"The potential role of patent and proprietary medicine vendors\u2019 associations in improving the quality of services in Nigeria\u2019s drug shops","volume":"20","author":"AS Oyeyemi","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pgph.0005251.ref022","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13063-019-3186-x","article-title":"Using discrete choice experiments to inform the design of complex interventions","volume":"20","author":"F Terris-Prestholt","year":"2019","journal-title":"Trials"},{"key":"pgph.0005251.ref023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005000","article-title":"Comparison of community-led distribution of HIV self-tests kits with distribution by paid distributors: a cluster randomised trial in rural Zimbabwean communities","volume":"6","author":"EL Sibanda","year":"2021","journal-title":"BMJ Glob Health"},{"key":"pgph.0005251.ref024","doi-asserted-by":"crossref","first-page":"21101","DOI":"10.7448\/IAS.19.7.21101","article-title":"PrEP implementation research in Africa: what is new?","volume":"19","author":"FM Cowan","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"pgph.0005251.ref025","article-title":"\u201cIt went through the roof\u201d: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19","author":"P Matambanadzo","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"pgph.0005251.ref026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003892","article-title":"The impact of the DREAMS partnership on HIV incidence among young women who sell sex in two Zimbabwean cities: results of a non-randomised study","volume":"6","author":"ST Chabata","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"1","key":"pgph.0005251.ref027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/QAI.0000000000002393","article-title":"Estimating the Population Size of Female Sex Workers in Zimbabwe: Comparison of Estimates Obtained Using Different Methods in Twenty Sites and Development of a National-Level Estimate","volume":"85","author":"E Fearon","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pgph.0005251.ref028","unstructured":"Vassall A, Sweeney S, Kahn J, Gomez Guillen G, Bollinger L, Marseille E, et al. Reference case for estimating the costs of global health services and interventions. 2017. https:\/\/researchonline.lshtm.ac.uk\/id\/eprint\/4653001\/1\/vassall_etal_2018_reference_case_for_estimating_costs_global_health_services.pdf"},{"key":"pgph.0005251.ref029","doi-asserted-by":"crossref","DOI":"10.1596\/1813-9450-10407","volume-title":"A framework for the economic evaluation of digital health interventions","author":"T Wilkinson","year":"2023"},{"issue":"1","key":"pgph.0005251.ref030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12916-021-02204-0","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"20","author":"D Husereau","year":"2022","journal-title":"BMC Med"},{"key":"pgph.0005251.ref031","article-title":"Economic cost analysis of door-to-door community-based distribution of HIV self-test kits in Malawi, Zambia and Zimbabwe","author":"C Mangenah","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"pgph.0005251.ref032","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005191","article-title":"Costs of integrating HIV self-testing in public health facilities in Malawi, South Africa, Zambia and Zimbabwe","volume":"6","author":"LA Sande","year":"2021","journal-title":"BMJ Glob Health"},{"key":"pgph.0005251.ref033","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005019","article-title":"The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa","volume":"6","author":"K Matsimela","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"7","key":"pgph.0005251.ref034","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.healthpol.2017.04.013","article-title":"Time-driven activity-based costing in health care: A systematic review of the literature","volume":"121","author":"G Keel","year":"2017","journal-title":"Health Policy"},{"issue":"4","key":"pgph.0005251.ref035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/heapol\/14.4.374","article-title":"A comparison of four approaches for measuring clinician time use","volume":"14","author":"JH Bratt","year":"1999","journal-title":"Health Policy Plan"},{"issue":"2","key":"pgph.0005251.ref036","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/heapol\/czh015","article-title":"Cost and unit cost calculations using step-down accounting","volume":"19","author":"L Conteh","year":"2004","journal-title":"Health Policy Plan"},{"issue":"1","key":"pgph.0005251.ref037","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10198-008-0101-x","article-title":"Comparing methodologies for the cost estimation of hospital services","volume":"10","author":"SS Tan","year":"2008","journal-title":"Eur J Health Econ"},{"key":"pgph.0005251.ref038","unstructured":"Consortium YYHE. Discount rate. 2016. https:\/\/yhec.co.uk\/glossary\/discount-rate\/"},{"key":"pgph.0005251.ref039","unstructured":"Malawi B of. Statistics\/Exchange rates. 2023. https:\/\/www.rbm.mw\/Statistics\/MajorRates\/"},{"key":"pgph.0005251.ref040","unstructured":"Nigeria CB of. Exchange rates. n.d. https:\/\/www.cbn.gov.ng\/rates\/exchratebycurrency.asp"},{"key":"pgph.0005251.ref041","unstructured":"Zimbabwe RB. Exchange Rates. 2023. https:\/\/www.rbz.co.zw\/index.php\/research\/markets\/exchange-rates"},{"key":"pgph.0005251.ref042","volume-title":"Methods for the economic evaluation of health care programmes","author":"M Drummond","year":"2002"},{"issue":"4","key":"pgph.0005251.ref043","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/hec.1363","article-title":"The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs gross-costing approaches","volume":"18","author":"FM Clement Nee Shrive","year":"2009","journal-title":"Health Econ"},{"issue":"10","key":"pgph.0005251.ref044","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/hec.1422","article-title":"Equivalence of two healthcare costing methods: bottom-up and top-down","volume":"18","author":"MK Chapko","year":"2009","journal-title":"Health Econ"},{"issue":"4","key":"pgph.0005251.ref045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-078852","article-title":"Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines)","volume":"14","author":"MA Hansen","year":"2024","journal-title":"BMJ Open"},{"issue":"6","key":"pgph.0005251.ref046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001999","article-title":"Testing for SARS-CoV-2 in resource-limited settings: A cost analysis study of diagnostic tests using different Ag-RDTs and RT-PCR technologies in Mozambique","volume":"3","author":"NJ Manjate","year":"2023","journal-title":"PLOS Glob Public Health"},{"issue":"5","key":"pgph.0005251.ref047","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/QAI.0000000000000699","article-title":"Estimating the Cost of Early Infant Male Circumcision in Zimbabwe: Results From a Randomized Noninferiority Trial of AccuCirc Device Versus Mogen Clamp","volume":"69","author":"C Mangenah","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pgph.0005251.ref048","unstructured":"UNAIDS, AW& JKKFF and ELC and JUNP on H. Donor government funding for HIV in low- and middle-income countries in 2020. 2020. https:\/\/www.unaids.org\/en\/resources\/presscentre\/featurestories\/2021\/july\/20210719_kff-analysis-funding"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:31:14Z","timestamp":1759944674000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005251"}},"subtitle":[],"editor":[{"given":"Julia","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0005251","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}